Participants 56 88 4
extensive small-cell lung cancer
Participants 287 377 3
previously untreated patients with extensive-stage small-cell carcinoma of the lung (SCLC)
Participants 400 531 6
Patients with extensive SCLC with a Karnofsky performance score (KPS) > or = 50 and adequate renal function and bone marrow reserve
Participants 547 589 4
Patients with CNS metastases were eligible
Participants 947 992 5
rom May 1989 through March 1993, 171 patients
Participants 1804 1832 3
patients with extensive SCLC
